ASTHMA
Clinical trials for ASTHMA explained in plain language.
Never miss a new study
Get alerted when new ASTHMA trials appear
Sign up with your email to follow new studies for ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo inhaler shows promise for uncontrolled asthma
Disease control CompletedThis study tested whether a combination inhaler containing two medicines (budesonide and formoterol) works better than an inhaler with just one medicine (budesonide) for people whose asthma is not well controlled. 374 adults and teens aged 12–80 took part over 12 weeks. The goal …
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
Vitamin d shows promise in cutting lung problems for kids with sickle cell
Disease control CompletedThis study looked at whether taking vitamin D every day can lower the risk of serious lung problems in children and teens with sickle cell disease. Lung issues like infections and acute chest syndrome are major causes of illness in this group. The study involved 58 participants a…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Head-to-Head drug showdown for stuffy noses and asthma sufferers
Disease control CompletedThis study compared two medications, dupilumab and omalizumab, in 360 adults with severe nasal polyps and asthma. The goal was to see which drug better shrinks polyps and improves sense of smell after 24 weeks. Participants received either drug and were monitored for symptom chan…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Salmon oil shows promise for asthma control in new study
Disease control CompletedThis study tested whether a salmon oil supplement called CARDIO® could reduce asthma attacks in adults. 70 people with asthma took either the supplement or a placebo for 20 weeks while continuing their usual asthma medications. The goal was to see if the supplement's anti-inflamm…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Hofseth Biocare ASA • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New asthma drug shows promise in phase 3 trial
Disease control CompletedThis study tested an experimental drug called QAW039 in 675 adults and teens with asthma that wasn't well controlled by their current medications. Participants took either QAW039 or a placebo pill alongside their usual asthma treatments for 12 weeks. The main goal was to see if Q…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New asthma drug shows promise for controlling symptoms and cough
Disease control CompletedThis study tested how well tezepelumab works for adults with severe asthma that is not controlled by other treatments. It focused on improving asthma control and reducing cough. 92 participants were followed for a year to see real-world effects.
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
Virtual Check-Ups after ER visits help kids breathe easier
Disease control CompletedThis study tested a program that uses video calls (telemedicine) to connect children with asthma to their primary care doctor within a week of an emergency room visit. The goal was to help kids get the right daily preventive medications and reduce asthma attacks. The program incl…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New asthma strategy could reduce severe attacks
Disease control CompletedThis study tested whether using the Foster inhaler for both daily control and quick relief works better than using it only for daily control with a separate rescue inhaler (salbutamol). Over 1,700 adults with not-fully-controlled asthma took part for 48 weeks. The goal was to see…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
Text reminders boost home spirometry in severe asthma
Disease control CompletedThis study tested whether weekly reminder messages help adults with severe asthma stay on track with home breathing tests. Thirty participants used a digital device to measure lung function at home for three months. Those who got reminders completed more tests than those who didn…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Medicine and Pharmacy "Victor Babes" Timisoara • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New asthma drug shows promise in Real-World study
Disease control CompletedThis study looked at how well the drug tezepelumab works for people with severe asthma in real-world settings, outside of a controlled lab. Over 500 participants tracked their symptoms and quality of life for months. The goal was to see if the drug helps control asthma day-to-day…
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New approach helps south africans better control HIV, diabetes, and more
Disease control CompletedThis study tested a program called ENHANCE to help people with two or more long-term health problems like HIV, high blood pressure, diabetes, asthma, or depression. Over 1,800 adults aged 40 and older took part. Some clinics used a special decision-support tool and home visits fr…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of KwaZulu • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New asthma drug shows promise in early trial
Disease control CompletedThis study tested a new drug called AZD4604 in 36 adults with moderate-to-severe asthma. The goal was to see if it reduces airway inflammation better than a placebo over 4 weeks. Participants took the drug or a placebo and had their airway cells checked for signs of inflammation.…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New allergy treatment shows promise in Real-World study
Disease control CompletedThis study tested an immunotherapy treatment (Clustoid® Max Forte) for people with dust mite allergies, including those with allergic rhinitis, asthma, or eye allergies. Researchers looked at 140 patients aged 5 to 65 who had been on the treatment for at least a year. They measur…
Matched conditions: ASTHMA
Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New asthma pill shows promise in large trial
Disease control CompletedThis study tested an experimental drug called QAW039 in 704 adults and teens (12 years and older) whose asthma was not well controlled despite using standard inhalers. Participants took either QAW039 or a placebo pill on top of their usual asthma medicines for 12 weeks. The main …
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Rural patients get hospital care at home in landmark trial
Disease control CompletedThis study looked at whether giving hospital-level care to acutely ill adults in their own homes in rural areas works well. 160 people with various conditions like infections, heart failure, or COPD took part. The main goal was to see if this approach could lower costs and keep p…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Asthma patients monitored on triple therapy in daily life
Disease control CompletedThis study followed 147 adults with moderate to severe asthma whose doctors prescribed the triple-combination inhaler Trimbow. Researchers observed how patients used the treatment in everyday settings and measured changes in asthma control, quality of life, and lung function. The…
Matched conditions: ASTHMA
Sponsor: Chiesi UK • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
App-Based coaching helps asthmatic teens breathe easier
Disease control CompletedThis study tested a smartphone-based program to help teenagers (ages 12-18) with moderate to severe asthma remember to take their daily inhaler medicine. 72 teens were split into two groups: one used the program, and the other received usual care. The program aimed to improve how…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New inhaler combo shows promise for Tough-to-Control asthma
Disease control CompletedThis study tested a new inhaler (CHF 1535) that combines a steroid and a long-acting bronchodilator against a standard steroid-only inhaler in 542 adults whose asthma was not well controlled with their current medications. The goal was to see if the combination inhaler improved m…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Asthma drug shows Real-World relief for severe cases in taiwan
Disease control CompletedThis study followed 43 adults in Taiwan with severe uncontrolled asthma who were prescribed benralizumab. Researchers tracked changes in asthma control using a standard questionnaire over time. The goal was to see how well the drug works in everyday life, not just in a lab.
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Triple inhaler helps asthma patients breathe easier in Real-World study
Disease control CompletedThis study looked at how well a triple-combination inhaler (BDP/FF/G) works for adults with asthma in everyday life. 281 people used the inhaler for 6 months, and researchers measured changes in their asthma control scores. The goal was to see if symptoms improved, not to cure as…
Matched conditions: ASTHMA
Sponsor: Chiesi Bulgaria • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Asthma drug shows promise in reducing lung blockages
Disease control CompletedThis study tested the drug tezepelumab in 27 adults with moderate-to-severe asthma that was not well controlled by current treatments. The goal was to see if the drug could improve how air moves through the lungs and reduce airway inflammation and mucus plugs. Participants receiv…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New asthma drug shows promise in reducing severe attacks
Disease control CompletedThis study looked at whether tezepelumab, an approved asthma medication, is safe and effective for people with severe asthma, especially those often left out of research. About 287 adults and teens took the drug for a year. The main goal was to see if it reduced the number of ser…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
ER-to-School asthma program aims to keep kids out of the hospital
Disease control CompletedThis study tested a program where children who came to the emergency room for an asthma attack were given their daily asthma medication right at the ER and then had it supervised at school. The goal was to see if this approach would help kids take their medicine regularly and red…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Breakthrough: 88% of patients with severe asthma and nasal polyps achieve dual remission on dupilumab
Disease control CompletedThis study looked at 28 adults with both severe asthma and chronic sinusitis with nasal polyps who were treated with dupilumab for 24 months. The goal was to see if the drug could help control both conditions at the same time, called 'dual remission.' After two years, 88% of pati…
Matched conditions: ASTHMA
Sponsor: Azienda Ulss 2 Marca Trevigiana • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New asthma combo boosts breathing for 12 hours
Disease control CompletedThis study tested whether adding an extra inhaler (glycopyrrolate) to a standard steroid inhaler (QVAR) helps adults whose asthma is not well controlled. 98 people took part, and the results showed that the combination improved lung function over a 12-hour period compared to plac…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New inhaler shows promise for better asthma control in Real-World study
Disease control CompletedThis study looked at 620 adults with asthma that was not well controlled by their current treatments. They used a combination inhaler (beclometasone/formoterol) delivered through the NEXThaler device for 6 months. The main goal was to see if their asthma control improved, based o…
Matched conditions: ASTHMA
Sponsor: Chiesi Italia • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Gene-Guided reflux drug shows promise for kids with uncontrolled asthma
Disease control CompletedThis study looked at 41 children aged 6-17 with both mild acid reflux and uncontrolled asthma. Researchers tested whether adjusting the dose of a common reflux medicine (lansoprazole) based on each child's genes could improve asthma control and reduce reflux symptoms. The goal wa…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Jason Lang, M.D., M.P.H. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Teens with asthma get help from phone apps and peer mentors in new study
Disease control CompletedThis study tested whether a technology-based education program, delivered by peer mentors and adult educators, could help 48 teens aged 14-17 with asthma. The program aimed to improve asthma control, quality of life, knowledge, and self-confidence. Results are not yet available, …
Matched conditions: ASTHMA
Phase: NA • Sponsor: Bartın Unıversity • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New asthma drug shows promise in reducing severe attacks
Disease control CompletedThis study tested a new drug called amlitelimab in 437 adults with moderate-to-severe asthma. Participants received either the drug or a placebo as an add-on to their usual asthma medications. The main goal was to see if amlitelimab could reduce the number of severe asthma attack…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New combo inhaler shows promise for better asthma control
Disease control CompletedThis study tested whether a combination inhaler (steroid plus a long-acting bronchodilator) works better than a steroid-only inhaler for adults with asthma. Over 1,300 participants used either the combo or the steroid-only inhaler for 12 weeks. The main goal was to see if the com…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
E-Cigs tested as Asthma-Friendly smoking swap
Disease control CompletedThis study looked at whether giving electronic cigarettes (e-cigarettes) to adults who smoke and have asthma could help them cut down on regular cigarettes and improve their lung function. Seventeen people took part, and researchers measured changes in smoking habits, asthma symp…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Brown University • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
New app helps teens take control of asthma
Disease control CompletedThis study tested a mobile health tool called AIM2ACT designed to help adolescents aged 12-15 with poorly controlled asthma and their caregivers better manage the condition. The goal was to see if using the app improves asthma control, measured by a standard questionnaire. The st…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New asthma drug shows promise in reducing attacks
Disease control CompletedThis study tested a new drug, lunsekimig, in 685 adults aged 18-80 with moderate-to-severe asthma. Participants received either the drug or a placebo as an add-on to their usual treatment. The main goal was to see if lunsekimig could reduce the number of asthma attacks and improv…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New inhaled drug shows promise for Hard-to-Control asthma
Disease control CompletedThis study tested an experimental inhaled medication called AZD8630 in 537 adults whose asthma is not well controlled despite using standard inhalers. Participants took the drug or a placebo once daily for 12 weeks. The goal was to see if the drug could prevent asthma attacks and…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Breakthrough asthma shot slashes steroid dependence in severe cases
Disease control CompletedThis study tested a monthly injection called tezepelumab in 305 adults with severe asthma who needed daily steroid pills. The goal was to see if the drug could help them safely reduce or stop their steroid use. Results showed many participants could lower their steroid dose witho…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New asthma inhaler shows promise in clinical trial
Disease control CompletedThis study tested a new inhaler medicine called AZD4604 in 339 adults with moderate-to-severe asthma that is not well controlled by their current treatments. Participants took the medicine or a placebo twice a day for 12 weeks. The goal was to see if the new medicine could reduce…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New inhaler combo shows promise for Hard-to-Control asthma
Disease control CompletedThis study tested whether adding a third medicine (glycopyrrolate) to a standard asthma inhaler (Foster) helps people whose asthma is not well controlled. About 211 adults with uncontrolled asthma took part. The main goal was to see if the new combination improved lung function o…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New inhaler combo shows promise for asthma sufferers
Disease control CompletedThis study tested a new inhaler that combines two asthma medicines (budesonide and formoterol) in one device. It involved 645 adults and teens aged 12-80 whose asthma was not well controlled. The goal was to see if this combination inhaler works better than using just one medicin…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
New asthma switch study could offer patients a convenient option
Disease control CompletedThis study tested whether switching adults and teens (12+) with severe eosinophilic asthma from current biologic treatments (mepolizumab or benralizumab) to a new drug called depemokimab (GSK3511294) is as good at preventing asthma attacks. Over 1,700 participants were followed f…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Asthma drug dupilumab tested for Long-Term safety in kids
Disease control CompletedThis study looked at the long-term safety of dupilumab in 378 children with asthma who had already taken the drug in a previous study. The main goal was to track side effects over one year. A smaller part of the study in Japan also checked how well the drug worked in kids aged 6 …
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 04, 2026 16:31 UTC
-
New asthma drug shows promise in Long-Term safety check
Disease control CompletedThis study looked at the long-term safety of a drug called depemokimab in 641 adults and teenagers with severe asthma that involves high levels of certain white blood cells (eosinophils). Participants who had already completed earlier studies received the drug for 12 months. The …
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Eco-Friendly asthma inhaler passes safety check in major trial
Disease control CompletedThis study tested a new version of a common asthma inhaler that uses a more environmentally friendly propellant. The goal was to make sure the new inhaler is just as safe and works as well as the current one for people with moderate to severe asthma. Over 800 adults took part in …
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
New asthma pill shows promise in reducing Flare-Ups
Disease control CompletedThis study tested an experimental daily pill called atuliflapon in 670 adults with moderate to severe asthma that is not well controlled by current treatments. The goal was to see if the drug could reduce asthma worsening episodes over 12 weeks compared to a placebo. The study is…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New hope for severe asthma: personalized treatments under the microscope
Disease control CompletedThis study tested several different treatments for people with severe asthma that is hard to control. About 950 participants each tried multiple treatments in a random order to see which worked best for them. The goal was to improve lung function and reduce asthma symptoms and fl…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Apr 24, 2026 16:07 UTC
-
Real-World asthma drug gets Long-Term safety check
Disease control CompletedThis study monitored the long-term safety and effectiveness of FASENRA injections in people with severe asthma. It involved 653 patients who were already prescribed this medication for asthma that wasn't controlled by standard treatments. Researchers tracked side effects and how …
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 23, 2026 12:44 UTC
-
New asthma drug tested to clear lungs of mucus and inflammation
Disease control CompletedThis study tested whether the drug dupilumab could reduce lung inflammation and mucus buildup in adults with moderate-to-severe asthma. Over 24 weeks, researchers compared dupilumab against a placebo in 109 participants, using special lung scans and breathing tests to measure cha…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 21, 2026 12:43 UTC
-
Schools step in to help kids breathe easier
Disease control CompletedThis study tested a school-based program to help children with asthma. For about 7 months, school nurses gave kids their daily preventive asthma medicine during the school day. The goal was to see if this routine helped reduce asthma symptoms, improve lung function, and cut down …
Matched conditions: ASTHMA
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Apr 13, 2026 20:21 UTC
-
Breath and blood tests could speed up asthma diagnosis
Diagnosis CompletedThis study looked at whether two simple tests—a breath test (FeNO) and a blood test—can help diagnose asthma more easily than current hospital-based breathing tests. Researchers studied 123 people with suspected asthma to see if these tests could accurately identify the disease a…
Matched conditions: ASTHMA
Sponsor: Université de Sherbrooke • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC
-
Vitamin d during pregnancy may shield kids from asthma
Prevention CompletedThis study looked at whether giving pregnant women extra vitamin D could stop their children from developing asthma or wheezing in early childhood. 876 pregnant women with a personal or family history of allergies took part. The main goal was to see if the children had asthma or …
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated May 17, 2026 02:05 UTC
-
New study tests oral extract to stop infant wheezing
Prevention CompletedThis study tested whether an oral bacterial extract called Broncho-Vaxom® could prevent wheezing lower respiratory tract illness in infants at high risk for asthma. Over 800 infants aged 6-18 months received the extract or a placebo for 10 days each month for two years. Researche…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated May 13, 2026 15:58 UTC
-
Thyme oil inhalation shows promise for asthma symptom relief
Symptom relief CompletedThis study tested whether inhaling thyme oil can improve asthma control and breathing in 156 adults with asthma. Participants used a thyme oil inhaler stick or a placebo (empty stick) three times daily for four days. The goal was to see if thyme oil reduces symptoms like wheezing…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Inonu University • Aim: Symptom relief
Last updated May 17, 2026 02:07 UTC
-
Inhaler vs nebulizer: which works faster for asthma attacks?
Symptom relief CompletedThis study tested two different devices for delivering the asthma rescue drug salbutamol: a standard inhaler with a spacer and a newer vibrating mesh nebulizer. 16 adults with asthma took part. Researchers measured how quickly and completely their lungs recovered after a controll…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: University of Saskatchewan • Aim: Symptom relief
Last updated May 17, 2026 02:07 UTC
-
Can a Salt-Like spray tame mild asthma?
Symptom relief CompletedThis study tested an inhaled Ectoin solution in 18 adults with mild asthma to find a safe and effective dose. Ectoin is a natural substance that may protect the airways. The main goal was to see if it reduces airway sensitivity to triggers like methacholine. Results were compared…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Bitop AG • Aim: Symptom relief
Last updated May 17, 2026 02:07 UTC
-
New asthma drug TR4 passes early safety check in small trial
Symptom relief CompletedThis early-stage study tested a new drug called TR4 in 12 adults with mild-to-moderate asthma. The goal was to see if it is safe and how it affects the airways. Participants received either TR4 or a placebo, and researchers measured lung function and other health signs. The study…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: Trio Medicines Ltd. • Aim: Symptom relief
Last updated May 17, 2026 02:06 UTC
-
App helps asthma patients breathe easier between checkups
Symptom relief CompletedThis study tested whether a smartphone app that lets people with asthma report their symptoms between doctor visits can improve their quality of life. Over 400 adults with asthma used the app or received usual care. Researchers measured changes in asthma-related quality of life a…
Matched conditions: ASTHMA
Phase: NA • Sponsor: RAND • Aim: Symptom relief
Last updated May 17, 2026 02:01 UTC
-
New asthma inhaler propellant passes safety check in large trial
Symptom relief CompletedThis study looked at the long-term safety of a new propellant (HFA-152a) used in salbutamol rescue inhalers for adults with asthma. It compared the new propellant to the current standard (HFA-134a) in 477 participants. The main goal was to see if the new propellant caused any sid…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Simple breathing and yoga may ease asthma symptoms, study finds
Symptom relief CompletedThis study looked at whether adding Bridge Pose yoga to Papworth breathing exercises helps teens and young adults with mild to moderate asthma. 58 participants practiced either breathing alone or breathing plus yoga for 8 weeks. Researchers measured shortness of breath, lung func…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Stretching away asthma symptoms: a new breath of fresh air?
Symptom relief CompletedThis study compared two types of stretching exercises—intercostal and thoracic cage—in 56 adults with asthma. The goal was to see if these stretches could improve chest expansion, reduce shortness of breath, and increase oxygen levels. Participants were clinically stable and did …
Matched conditions: ASTHMA
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Pink or white? asthma inhaler color may influence symptom perception
Symptom relief CompletedThis study looked at whether the color of an asthma inhaler (pink or white) affects how people with moderate-to-severe asthma perceive their symptoms. 78 adults who already used a specific inhaler took part. The goal was to see if the device's color could change symptom awareness…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
App-Based exercise program aims to ease asthma symptoms in obese adults
Symptom relief CompletedThis study tested whether a 12-week remote digital exercise program using a mobile app called Vitala is feasible and helpful for 20 adults with obesity and poorly controlled asthma. Participants received a personalized exercise plan and were encouraged to do 150 minutes of activi…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Vermont • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Home workouts may ease asthma symptoms, small study suggests
Symptom relief CompletedThis study tested an 8-week home-based pulmonary rehabilitation program for 30 adults with asthma. Participants did simple exercises using basic equipment to improve their breathing, exercise capacity, and quality of life. The goal was to see if a convenient, low-cost program cou…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Which asthma drug works best for kids? study reveals surprising results
Symptom relief CompletedThis study looked at 101 children aged 6 to 17 who came to the emergency room with a moderate or severe asthma attack. Researchers compared two medications—racemic albuterol and levalbuterol—to see which one improved breathing better and reduced hospital stays. The goal was to fi…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Phoenix Children's Hospital • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
New asthma inhaler PT007 put to the test against ventolin
Symptom relief CompletedThis study tested a new asthma inhaler called PT007 in 118 adults with asthma. Participants received a single dose of PT007, a placebo, or the standard inhaler Ventolin on different days to compare how well each opens the airways. The main goal was to measure lung function improv…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
New asthma inhaler drug tested in teens – early results show promise
Symptom relief CompletedThis early-stage study tested a single inhaled dose of a new drug called AZD8630 in 10 teenagers with asthma. The goal was to see how the drug moves through the body and to check for any safety issues. Participants used a dry powder inhaler and were monitored for side effects and…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
New asthma drug IBI3002 passes first safety check in small study
Symptom relief CompletedThis early-stage study tested a single dose of a new drug called IBI3002 in 52 healthy adults and people with mild-to-moderate asthma. The main goal was to check if the drug is safe and how the body processes it. Participants were randomly assigned to receive either the drug or a…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Can existing drugs ease bladder and asthma troubles in liver disease?
Symptom relief CompletedThis study tested two approved drugs, mirabegron and montelukast, in 78 adults with liver cirrhosis who also had overactive bladder and asthma. The goal was to see if the drugs are safe and help control bladder and asthma symptoms. Researchers used computer models to choose doses…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Swimming plus breathing training boosts asthma control in kids
Symptom relief CompletedThis study looked at whether adding special breathing exercises (inspiratory muscle training) to a swimming program could improve lung function and asthma control in children with mild asthma. Thirty children aged 8 to 11 took part in a 4-week program. One group did swimming only…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Gümüşhane Universıty • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
Could a single drug quiet a debilitating chronic cough?
Symptom relief CompletedThis study tested whether mepolizumab, a drug that reduces certain immune cells (eosinophils), can lessen chronic cough in people with asthma or eosinophilic bronchitis. 46 adults with a cough lasting over 8 weeks and high eosinophil levels participated. The main goal was to see …
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: McMaster University • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
New inhaled asthma drug shows promise in early trial
Symptom relief CompletedThis early-stage study tested an inhaled drug called ARO-RAGE in 127 healthy volunteers and people with asthma. The goal was to check safety and how the drug affects lung function. Participants received either the drug or a placebo, and researchers monitored side effects and brea…
Matched conditions: ASTHMA
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC
-
Smart inhaler app helps asthma patients breathe easier?
Symptom relief CompletedThis study tested whether a digital inhaler system (a smart inhaler connected to an app) helps people with asthma improve their symptom control. About 333 people aged 13 and older with poorly controlled asthma used either the smart inhaler or their usual rescue inhaler for 12 wee…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
New asthma inhaler combo shows promise in easing sudden breathing trouble
Symptom relief CompletedThis study tested whether a new inhaler (PT027) that combines a fast-acting reliever (albuterol) with an anti-inflammatory (budesonide) works better than albuterol alone for sudden asthma attacks. 190 adults with mild asthma who only used rescue inhalers as needed took part. Rese…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC
-
Can a Mitochondria-Targeting supplement ease asthma in obesity?
Symptom relief CompletedThis study tested whether MitoQ, a supplement that targets cell energy centers, can improve airway function in obese adults with poorly controlled asthma. Over 14 weeks, 47 participants received either MitoQ or a placebo. The main goal was to see if MitoQ reduces airway reactivit…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated May 11, 2026 20:46 UTC
-
New asthma inhaler propellant tested for safety in 52 patients
Symptom relief CompletedThis study tested whether a new propellant (HFO) used in asthma inhalers causes sudden airway narrowing (bronchospasm) compared to the standard propellant (HFA). 52 adults with well-controlled or partially controlled asthma took part. Researchers measured lung function right afte…
Matched conditions: ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated May 11, 2026 20:46 UTC
-
Acupuncture needles take on asthma: a new hope for breathing easier?
Symptom relief CompletedThis study looked at whether acupuncture can help people with mild-to-moderate asthma control their symptoms better. About 200 adults took part, and researchers measured things like asthma control, lung function, and how often they needed rescue medication. The goal was to see if…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC
-
New asthma inhaler shows promise in early trial
Symptom relief CompletedThis early-stage study tested a new inhaled medicine called AZD8630 in 24 adults with asthma who already use medium-to-high dose steroid inhalers plus long-acting bronchodilators. Participants took the drug once daily for 2 weeks to check for side effects, how the body processes …
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated May 08, 2026 12:01 UTC
-
New study tracks real-world asthma drug benefits on daily life
Symptom relief CompletedThis study followed 112 adults with severe asthma who started taking dupilumab (Dupixent). Researchers measured changes in quality of life using a standard questionnaire at 12, 24, and 52 weeks. The goal was to see how the drug helps people breathe easier and feel better in every…
Matched conditions: ASTHMA
Sponsor: Sanofi • Aim: Symptom relief
Last updated May 07, 2026 18:39 UTC
-
Video-Call exercises ease asthma symptoms in young adults
Symptom relief CompletedThis study looked at whether doing breathing and posture exercises through video calls (telerehabilitation) could help young adults with asthma breathe better, stand straighter, and feel better overall. Twelve people with stable asthma took part. The results may show that simple …
Matched conditions: ASTHMA
Phase: NA • Sponsor: Yeditepe University • Aim: Symptom relief
Last updated May 07, 2026 18:38 UTC
-
BREATHING EASY: simple technique may ease asthma fatigue
Symptom relief CompletedThis study looked at whether the Buteyko breathing technique can reduce fatigue, improve exercise ability, and help control asthma in people with asthma. 90 adults with asthma were split into two groups: one learned the Buteyko method, and the other did not. Researchers measured …
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Gaziantep • Aim: Symptom relief
Last updated May 06, 2026 16:01 UTC
-
New asthma drug passes early safety check in small trial
Symptom relief CompletedThis early-stage study tested a new drug called SAR443765 in 36 people to see if it is safe and how the body processes it. Healthy volunteers received single or multiple doses, while people with mild-to-moderate asthma got a single dose. The main goal was to check for side effect…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 04, 2026 16:23 UTC
-
Depression changes asthma in kids – new study finds a better inhaler for them
Knowledge-focused CompletedThis study looked at 39 children with asthma to see if those with depression have different lung inflammation and respond better to a specific inhaler (ipratropium). The goal was to understand a new asthma type linked to depression. Results may help personalize asthma treatment f…
Matched conditions: ASTHMA
Phase: EARLY_PHASE1 • Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC
-
Real-World data shows Tezepelumab's impact on severe asthma patients
Knowledge-focused CompletedThis study reviewed medical records of 420 people with severe asthma who received tezepelumab after it was approved in Spain. The goal was to see how patients fared in real life, including asthma attacks and symptom control. It did not test a new treatment but gathered informatio…
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC
-
Scientists probe asthma attacks to find hidden triggers
Knowledge-focused CompletedThis study looked at blood and airway samples from 23 adults during an asthma attack and again after recovery. The goal was to find out what happens in the body during a severe flare-up. The results may help scientists develop better treatments for asthma in the future.
Matched conditions: ASTHMA
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC
-
Protein fingerprints may unlock better lung disease tracking
Knowledge-focused CompletedThis study looked at whether a family of proteins called GPCRs can be used as biomarkers to diagnose or track chronic lung diseases like asthma and COPD. Researchers analyzed blood samples from 205 participants (healthy people and patients) to find unique GPCR patterns for each d…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC
-
Farm life may shield kids from severe colds and asthma
Knowledge-focused CompletedThis study looked at whether growing up on a farm, with exposure to many different microbes, helps children build stronger immune systems. Researchers tracked 290 kids aged 4 to 12, including farm children and city children with and without asthma. They measured how often and how…
Matched conditions: ASTHMA
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 17, 2026 02:05 UTC
-
Inhaler propellant showdown: does the new one keep lungs as clean?
Knowledge-focused CompletedThis study tested whether a new inhaler propellant (HFA-152a) affects the lungs' ability to clear mucus compared to a standard propellant (HFA-134a). Twenty-four healthy adults inhaled each propellant for a week, and researchers measured mucus clearance using a radioactive tracer…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC
-
Asthma steroids linked to bone loss in large study
Knowledge-focused CompletedThis study looked at nearly 20,000 adults with asthma to see if long-term use of inhaled or oral steroids increases the risk of bone thinning (osteoporosis) and other metabolic problems like diabetes and high blood pressure. Researchers compared people who took higher doses of st…
Matched conditions: ASTHMA
Sponsor: Ajou University School of Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC
-
New program helps doctors better manage asthma in china
Knowledge-focused CompletedThis study tested a program to train doctors on the latest asthma guidelines and help them put that knowledge into practice. About 1500 people with asthma from 30 hospitals in China took part. The goal was to see if the program led to better use of inhaled steroids and improved a…
Matched conditions: ASTHMA
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC
-
Asthma study probes why RSV hits harder
Knowledge-focused CompletedThis study looked at whether a chemical called TGF-Beta, found in higher levels in the lungs of people with asthma, makes them more likely to get severe infections from RSV, a common respiratory virus. Researchers collected lung cells from 113 healthy adults and mild asthmatics u…
Matched conditions: ASTHMA
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC
-
Asthma patients breathe easier? new study tests nasal airflow therapy
Knowledge-focused CompletedThis study looked at how a treatment called nasal high-flow therapy (NHFT) affects breathing and the body's 'fight-or-flight' nerve signals in 30 adults with asthma. Researchers measured heart rate, blood pressure, and nerve activity to see if NHFT changes these patterns. The goa…
Matched conditions: ASTHMA
Sponsor: RWTH Aachen University • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC
-
Asthma drug candidate tested in healthy people for first time
Knowledge-focused CompletedThis study tested a single injection of HBM9378 (SKB378) in 50 healthy Chinese adults to see if it is safe and how the body processes it. The goal was not to treat asthma but to gather early safety and drug-level information. Participants were healthy, not asthma patients, and th…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: Harbour BioMed (Guangzhou) Co. Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC
-
Breath by breath: new study aims to Fine-Tune inhaler drug delivery
Knowledge-focused CompletedThis study measured breathing patterns in 163 people with asthma or COPD to help computer models predict how much of an inhaled drug actually reaches the lungs. Researchers hope to find links between breathing, disease severity, and drug deposition. The goal is to make aerosol th…
Matched conditions: ASTHMA
Sponsor: Medisol Development Kft. • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC
-
Farm chemical exposures under microscope in massive health Follow-Up
Knowledge-focused CompletedThis study follows nearly 90,000 farmers and their spouses to track long-term health effects from pesticides and farm work. Researchers confirm self-reported diseases like asthma and Parkinson's by reviewing medical records and collecting cheek swabs. The goal is to understand ho…
Matched conditions: ASTHMA
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Blood type linked to asthma Flare-Ups?
Knowledge-focused CompletedThis study looked at whether a person's blood group antigens are connected to asthma attacks. Researchers followed 126 people with asthma to see if certain blood types had more flare-ups needing steroids. The goal was to understand, not to test a new treatment.
Matched conditions: ASTHMA
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Dupilumab in pregnancy: no major safety signals found
Knowledge-focused CompletedThis study looked at the safety of using dupilumab during pregnancy in women with atopic dermatitis or asthma. Researchers compared pregnancy and infant outcomes between women who took dupilumab and those who did not. The goal was to see if the drug increased the risk of birth de…
Matched conditions: ASTHMA
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Long-Term asthma study reveals Real-World treatment patterns
Knowledge-focused CompletedThis study followed 18 adults with severe asthma for at least 3 years to understand how their condition is managed in real life. Researchers collected data on treatments, hospital visits, symptoms, and quality of life through surveys and medical records. No new drugs or treatment…
Matched conditions: ASTHMA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
New app puts chronic disease management in your pocket
Knowledge-focused CompletedThis study checked how easy and acceptable the P-STEP mobile app is for people with chronic conditions like asthma, COPD, heart disease, or type 2 diabetes. 178 adults in Leicester, UK, used the app for 12 weeks. The goal was to see if the app is user-friendly and helpful for man…
Matched conditions: ASTHMA
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Asthma Drug's hidden effects revealed in small study
Knowledge-focused CompletedThis study looked at how mepolizumab, a drug for severe eosinophilic asthma, changes inflammation in the nose, airways, and body. Researchers measured immune markers and metabolic profiles in 15 adults. The goal was to better understand the drug's full effects, not to test a new …
Matched conditions: ASTHMA
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Asthma drug levels compared in teens and adults
Knowledge-focused CompletedThis study looked at how much of the asthma drug CHF 6001 enters the blood of teenagers with asthma compared to adults. About 50 people took a single dose of the drug via an inhaler. The goal was to see if the drug behaves similarly in both age groups, which helps doctors decide …
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Asthma drug mystery: blood levels may explain why some patients Don't respond
Knowledge-focused CompletedThis study measured the amount of mepolizumab in the blood of 50 adults with severe asthma to see if drug levels differ between those who respond well and those who don't. Participants had been on mepolizumab for at least 6 months. The goal was to understand if differences in how…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
New drug for asthma and eczema passes first safety check in healthy people
Knowledge-focused CompletedThis early-stage study tested a new drug called 9MW1911 in 48 healthy adults to see if it is safe and how the body processes it. No treatment was given for any disease. The results will help decide safe doses for future studies in people with asthma, COPD, or atopic dermatitis.
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Can your chest muscles predict asthma treatment success?
Knowledge-focused CompletedThis study looked at CT scans from 233 people with severe asthma to see if body composition (like chest muscle size and quality) could predict how well they respond to biologic therapies. Researchers used advanced image analysis to find patterns linked to fewer asthma attacks. Th…
Matched conditions: ASTHMA
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
New study probes Dupilumab's inner workings in asthma patients with obesity
Knowledge-focused CompletedThis study looked at how the drug dupilumab changes gene and protein activity in airway cells from adults with allergic asthma and obesity (BMI 30 or higher). Researchers collected nasal cells from 28 participants to see how dupilumab affects inflammation signals. The goal was to…
Matched conditions: ASTHMA
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Asthma lessons boost Kids' Know-How and quality of life
Knowledge-focused CompletedThis study looked at whether teaching children aged 7-11 with asthma about their condition can improve their asthma knowledge, control, and quality of life. 70 children and their families participated, using online tools to learn. The goal was to see if education alone can make a…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Dokuz Eylul University • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Stepping up asthma care: new test may gauge fitness
Knowledge-focused CompletedThis study looked at whether a 6-minute stepper test (stepping up and down on a small platform) is a valid and reliable way to measure exercise capacity in adults with asthma. 41 people with well-controlled asthma participated. The goal was to see if this simple test could replac…
Matched conditions: ASTHMA
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
AI predicts hospital return risk in home care patients
Knowledge-focused CompletedThis study looked at data from 372 patients who were part of a home hospital program. Researchers used a computer program (machine learning) to see if it could predict which patients would need to be readmitted to the hospital within 30 days. The goal was to learn if this approac…
Matched conditions: ASTHMA
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
New inhaler gas passes early safety check in healthy volunteers
Knowledge-focused CompletedThis study tested a new propellant (HFA-152a) in salbutamol inhalers to see if it delivers the drug similarly to the current propellant (HFA-134a). Sixty healthy adults aged 18-55 received single doses of 200 or 800 micrograms in a crossover design. The goal was to compare how mu…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Cough-Counting app tested in 616 patients
Knowledge-focused CompletedThis study tested a smartphone app called Hyfe Cough Tracker to see if it can accurately count coughs in people with respiratory conditions like COPD, asthma, and COVID-19. Researchers compared the app's cough counts to patients' own reports and to human listeners. The goal was t…
Matched conditions: ASTHMA
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Gene hunt: why asthma hits african descendants harder?
Knowledge-focused CompletedThis study aimed to find genetic and environmental factors that cause asthma in people of African, African American, or African Caribbean descent. Researchers collected health questionnaires, blood, skin, and breathing test data from 83 adults with or without asthma. No treatment…
Matched conditions: ASTHMA
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Can cutting salt and sugar tame steroid side effects?
Knowledge-focused CompletedThis study looked at whether a diet low in salt and sugar can reduce common side effects of corticosteroid treatment, like weight gain, high blood pressure, and diabetes. Fifty adults with autoimmune diseases or asthma who were starting high-dose steroids participated. Researcher…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
Asthma study probes deep lung inflammation with new inhaler particles
Knowledge-focused CompletedThis study looked at inflammation in the small airways of the lungs in people with mild to moderate asthma. Researchers tested whether a steroid with small particles could reach deeper into the lungs better than a large-particle steroid. 57 adults took part, using lung function t…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
New antibody tested in healthy volunteers – no cure yet
Knowledge-focused CompletedThis early-stage study tested a single dose of the SM17 antibody in 30 healthy Chinese adults to see if it is safe and how the body processes it. The goal was not to treat any disease, but to gather important safety and drug-level information. No direct benefit was expected for p…
Matched conditions: ASTHMA
Phase: PHASE1 • Sponsor: SinoMab BioScience Ltd • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
Lung fluid samples shed light on asthma inflammation
Knowledge-focused CompletedThis study collected fluid and cells from the lungs of 574 people with asthma and healthy volunteers using a thin tube called a bronchoscope. The goal was to learn more about what causes airway inflammation in asthma. No treatment was given; the study was purely for research to f…
Matched conditions: ASTHMA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC
-
Gene study reveals clues to immune system imbalance in allergies
Knowledge-focused CompletedThis study looked at how small changes in the COX-2 gene affect the balance of immune cells that can lead to allergies or asthma. Researchers collected blood and urine samples from 117 adults to analyze these gene variations. No treatments were given; the goal was simply to under…
Matched conditions: ASTHMA
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC
-
Smart inhalers reveal how kids really use asthma rescue meds
Knowledge-focused CompletedThis study looked at how 120 children with asthma and their families use emergency inhalers at home during asthma attacks. Using smart inhalers that track usage, researchers aimed to understand real-world patterns to create better, more practical asthma action plans. The goal was…
Matched conditions: ASTHMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC
-
Helping Mom's mood may ease Kid's asthma
Knowledge-focused CompletedThis study looked at 205 pairs of caregivers with major depression and their children (ages 7-17) with asthma. Instead of a controlled trial, researchers tracked both over a year to see if improvements in the caregiver's depression led to better asthma control in the child. The g…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC
-
New study monitors hospitalized kids with lung infections
Knowledge-focused CompletedThis study observed over 1,800 children hospitalized for serious breathing issues like bronchiolitis, pneumonia, or asthma. It aimed to track how many children were hospitalized for bronchiolitis after a new immunization became available. The study did not test any new treatment,…
Matched conditions: ASTHMA
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC
-
Can severe asthma treatment boost your work performance?
Knowledge-focused CompletedThis study looked at 174 adults with severe asthma who were starting a new biologic treatment (biotherapy). The goal was to see if their ability to work and be productive at their jobs improved after 6 months of treatment. Researchers measured presenteeism, which means being at w…
Matched conditions: ASTHMA
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC
-
Bakers' asthma linked to grass pollen? new study digs into the connection.
Knowledge-focused CompletedThis study looked at over 400 adults with asthma to see if grass pollen allergies are more common in bakers and pastry chefs exposed to flour compared to other workers. Researchers reviewed medical records from a French hospital to find patterns that could help prevent work-relat…
Matched conditions: ASTHMA
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC
-
AI spots danger signs in homebound patients before they worsen
Knowledge-focused CompletedThis study looked at whether a computer program could predict when patients being treated at home might suddenly get worse. Researchers used data from 526 patients to train and test the program. The goal was to see if the program could alert doctors early, helping prevent serious…
Matched conditions: ASTHMA
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC
-
Can exercise change asthma genes? new study says yes
Knowledge-focused CompletedThis study looked at how different breathing exercises affect genes and symptoms in 84 adults with severe asthma. Participants did either standard breathing rehab or the same program plus extra muscle-strengthening exercises. Researchers measured changes in lung function, exercis…
Matched conditions: ASTHMA
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC
-
Can a paper letter save the planet and asthma patients?
Knowledge-focused CompletedThis study looked at whether sending paper letters along with emails to doctors helps them switch patients to asthma inhalers that are better for the environment. 273 primary care practices in the UK took part. The goal was to see if this approach increases the use of 'low-global…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of Leeds • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC
-
Obesity and asthma: new imaging reveals hidden lung damage
Knowledge-focused CompletedThis study looked at why obese people with asthma often have more severe symptoms and don't respond well to standard treatments. Researchers used special MRI scans and genetic analysis to examine lung changes in 49 obese adults with asthma. The goal was to better understand the r…
Matched conditions: ASTHMA
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC
-
New study aims to improve hospital care for kids with common breathing problems
Knowledge-focused CompletedThis study tested whether a set of care guidelines helps doctors in community hospitals use proven treatments for children with asthma, pneumonia, or bronchiolitis. Over 11,000 children took part across multiple hospitals. The goal was to see if these guidelines lead to better us…
Matched conditions: ASTHMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC
-
Can a smartphone app help people with asthma breathe easier?
Knowledge-focused CompletedThis pilot study tested whether a mobile app paired with a Bluetooth peak flow meter could help track asthma symptoms in 83 patients, including pregnant women. The goal was to see if the approach was practical and acceptable. Participants used the app to send their peak flow read…
Matched conditions: ASTHMA
Sponsor: Linnea Polgreen • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC
-
New asthma drug candidate passes early safety check in healthy people
Knowledge-focused CompletedThis study tested an experimental drug called XKH001 in 24 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo by injection multiple times. The goal was to check for side effects and measure drug levels in the bloo…
Matched conditions: ASTHMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Kanova Biopharmaceutical Co., LTD • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:38 UTC
-
Scientists track severe asthma to unlock new treatments
Knowledge-focused CompletedThis study followed 171 adults with severe asthma, mild-to-moderate asthma, or no asthma over several years. Researchers collected health data, lung tests, and samples to understand how severe asthma progresses and what complications arise. The goal is to find new ways to treat p…
Matched conditions: ASTHMA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:36 UTC
-
Major study tracks 2,660 kids to unlock asthma triggers
Knowledge-focused CompletedThis study aimed to better understand what causes asthma attacks and loss of control in children. Researchers followed 2,660 children and teenagers with asthma over time, collecting samples like saliva and urine. The goal was to identify environmental factors and other predictors…
Matched conditions: ASTHMA
Sponsor: Stefania La Grutta, MD • Aim: Knowledge-focused
Last updated Apr 20, 2026 16:14 UTC